GLP-1s Gave Me the Ick: A Personal Metabolic Experiment
July 25, 2026 · 18 min
Why listen
A week-by-week account of what tirzepatide actually does to your body, mood, and motivation.
Enjoy the episode?
Subscribe to Commune with Jeff Krasno
In this episode
- What changed in appetite, weight, and energy in the first two weeks
- How blood sugar, LDL, and ApoB shifted with CGM and blood panel tracking
- Why alcohol and coffee stopped feeling rewarding on the drug
- The real trade-off between appetite control and losing your sense of spark
About this episode
Ten pounds in two weeks. No hunger. No craving for coffee or alcohol. This is Jeff’s personal, week-by-week account of starting tirzepatide (sold as Zepbound), tracked through blood sugar, cholesterol markers, and a noticeable dimming of everyday motivation and joy.
- What changed in the first two weeks: appetite, weight, and energy
- Tracking glucose, LDL, ApoB, and other metabolic markers with a CGM and blood panels
- Why alcohol and coffee stopped feeling rewarding
- The emerging link between GLP-1s, dopamine, and the brain's reward circuitry
- The trade-off between appetite control and a sense of vitality or spark
This episode is for anyone weighing GLP-1s for themselves, or curious what the drugs are actually like beyond the headlines.
This episode was made possible by:
- CocoaVia:. Use code COMMUNE2026 for 25% off at CocoaVia.com
- LMNT: Get a free 8-count Sample Pack of LMNT’s most popular drink mix flavors with any purchase at drinklmnt.com/commune.
- Stemregen: Get 20% off your first order at stemregen.co/commune with the code COMMUNEPOD
- Vivobarefoot: Try Vivobarefoot risk-free with a 100-day return guarantee, and get 25% off your order at vivobarefoot.com/commune.
- Stripes: Visit stripesbeauty.com and use the code COMMUNE20 for 20% off our entire product line.

About Commune with Jeff Krasno
The Commune Podcast is where we explore the ideas and practices that help us live healthy, connected, purpose-filled lives.
See all episodes →






